IDS: A Drug Target for Urea Cycle Enzyme (G3423)

Target Name: IDS

NCBI ID: G3423

Content of Review Report on IDS Target / Biomarker

IDS

IDS: A Drug Target for Urea Cycle Enzyme

IDS (Idursulfase) is a protein that is expressed in various tissues of the body, including muscle, heart, brain, and liver. It is a key enzyme in the urea cycle, a process that is responsible for the production of proteins from amino acids. The urea cycle is a critical pathway for the regulation of protein synthesis and is involved in the production of proteins that are essential for various cellular functions. Therefore, alterations in the urea cycle have been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and chronic diseases.

The urea cycle is also a target for many drugs that are used to treat various diseases, including cancer, neurodegenerative diseases, and chronic diseases. Many of these drugs work by inhibiting the activity of the urea cycle enzyme, either by inhibiting the synthesis of urea or by inhibiting the activity of the enzyme itself. Therefore, IDS is a drug target that may be useful for the development of new treatments for various diseases.

Idursulfase is a protein that is expressed in various tissues of the body, including muscle, heart, brain, and liver. It is a key enzyme in the urea cycle, a process that is responsible for the production of proteins from amino acids. The urea cycle is a critical pathway for the regulation of protein synthesis and is involved in the production of proteins that are essential for various cellular functions. Therefore, alterations in the urea cycle have been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and chronic diseases.

The urea cycle is also a target for many drugs that are used to treat various diseases, including cancer, neurodegenerative diseases, and chronic diseases. Many of these drugs work by inhibiting the activity of the urea cycle enzyme, either by inhibiting the synthesis of urea or by inhibiting the activity of the enzyme itself. Therefore, IDS is a drug target that may be useful for the development of new treatments for various diseases.

Idursulfase is a protein that is expressed in various tissues of the body, including muscle, heart, brain, and liver. It is a key enzyme in the urea cycle, a process that is responsible for the production of proteins from amino acids. The urea cycle is a critical pathway for the regulation of protein synthesis and is involved in the production of proteins that are essential for various cellular functions. Therefore, alterations in the urea cycle have been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and chronic diseases.

The urea cycle is also a target for many drugs that are used to treat various diseases, including cancer, neurodegenerative diseases, and chronic diseases. Many of these drugs work by inhibiting the activity of the urea cycle enzyme, either by inhibiting the synthesis of urea or by inhibiting the activity of the enzyme itself. Therefore, IDS is a drug target that may be useful for the development of new treatments for various diseases.

Idursulfase is a protein that is expressed in various tissues of the body, including muscle, heart, brain, and liver. It is a key enzyme in the urea cycle, a process that is responsible for the production of proteins from amino acids. The urea cycle is a critical pathway for the regulation of protein synthesis and is involved in the production of proteins that are essential for various cellular functions. Therefore, alterations in the urea cycle have been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and chronic diseases.

The urea cycle is also a target for many drugs that are used to treat various diseases, including cancer, neurodegenerative diseases, and chronic diseases. Many of these drugs work by inhibiting the activity of the urea cycle enzyme, either by inhibiting the synthesis of urea or by inhibiting the activity of the enzyme itself. Therefore, IDS is a drug target that may be useful for the development of new treatments for various diseases.

The urea cycle is a critical pathway

Protein Name: Iduronate 2-sulfatase

Functions: Lysosomal enzyme involved in the degradation pathway of dermatan sulfate and heparan sulfate

The "IDS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IDS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets